Allergan, plc. (NYSE: AGN) today announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market 28 additional styles of Natrelle ® 410 silicone-filled ...

Allergan Plc (NYSE:AGN) is trading higher in the market early into the New Year, after clinching FDA approval for its breast implant treatment, Natrelle Inspira. The approval goes a long way in ...

The US Food and Drug Administration has approved Allergan's Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Gel Filled Breast Implant to increase breast size (augmentation) in women at least ...

Breast implants are not considered lifetime devices. The longer people have them, the greater the chances are that they will develop complications, some of which will require more surgery. Breast ...

PatientFi ®, a point of sale financing company that helps make elective procedures more affordable for patients, announces it has entered into a co-marketing agreement with Allergan Aesthetics, an ...

AbbVie subsidiary Natrelle recently debuted its For Every BODY campaign to show how the brand’s breast implant offerings can benefit patients with varying body types. As part of the promotional effort ...

Nine women from across the U.S. share their personal experiences with breast augmentation and reconstruction with Natrelle ® – celebrating confidence, self-expression, and restoration. Following a ...